RichardA.SchatzMD

PubMed

• 9 citations
  Effect of cardiosphere-derived cells on segmental myocardial function after myocardial infarction: ALLSTAR randomised clinical trial.
  Mohammad R. Ostovaneh, Raj Makkar, Bharath Ambale-Venkatesh, Deborah D. Ascheim, Tarun Chakravarty, Timothy D. Henry, Glen Kowalchuk, Frank V. Aguirre, Dean J. Kereiak...> ;Open Heart. 2021 Jul 1
• 1 citations
  How Coronary Stents Became a Reality: A Firsthand Account by an Innovator in the Field.
  Guillaume Marquis-Gravel, Richard A. Schatz> ;The Canadian Journal of Cardiology. 2021 Mar 25
• 1 citations
  Novel intracoronary supersaturated oxygen treatment for anterior myocardial infarction.
  Carmen Wheeler, Federico De Puy, Richard A. Schatz> ;Future Cardiology. 2021 Jan 15
• Rare survival of left ventricular free wall rupture following myocardial infarction.
  Carmen Wheeler, Rola Khedraki, Srikanth Seethala, Richard A. Schatz> ;Future Cardiology. 2021 Aug 1
• 68 citations
  Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial.
  Raj Makkar, Dean J. Kereiakes, Frank V. Aguirre, Glenn Kowalchuk, Tarun Chakravarty, Konstantinos Malliaras, Gary S. Francis, Thomas J. Povsic, Richard A. Schatz, Jay ...> ;European Heart Journal. 2020 Sep 21
• 2 citations
  "Protocol for a phase 2, randomized, double-blind, placebo-controlled, safety and efficacy study of dutogliptin in combination with filgrastim in early recovery post-m...
  Dirk von Lewinski, Joseph B. Selvanayagam, Richard A. Schatz, Bernd Jilma, Jacek Kubica, Thomas J. Povsic, Darrell Nix, Stephan Henauer, Markus Wallner> ;Trials. 2020 Aug 26
• The Wisdom of Restraint.
  Richard A. Schatz> ;JACC. Cardiovascular Interventions. 2018 Nov 26
• 3 citations
  Public unawareness of physician reimbursement
  Nicole L. Herrick, John Fontanesi, Toni Rush, Richard A. Schatz> ;Catheterization and Cardiovascular Interventions. 2018 May 1
• 68 citations
  Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of ran...
  Timothy D. Henry, Douglas W. Losordo, Jay H. Traverse, Richard A. Schatz, E. Marc Jolicoeur, Gary L. Schaer, Robert M. Clare, Karen Chiswell, Christopher J. White, F. ...> ;European Heart Journal. 2018 Jun 14
• 79 citations
  The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction
  Timothy D. Henry, Carl J. Pepine, Charles R. Lambert, Jay H. Traverse, Richard A. Schatz, Marco A. Costa, Thomas J. Povsic, R. David Anderson, James T. Willerson, Stev...> ;Catheterization and Cardiovascular Interventions. 2017 Feb 1
• 61 citations
  ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design.
  Tarun Chakravarty, Raj Makkar, Deborah D. Ascheim, Jay H. Traverse, Richard A. Schatz, Anthony N. DeMaria, Gary S. Francis, Thomas J. Povsic, Rachel R Smith, Joao A.C....> ;Cell Transplantation. 2017 Feb 1
• 91 citations
  PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular...
  Arshed A. Quyyumi, Alejandro Vasquez, Dean J. Kereiakes, Marc Klapholz, Gary L. Schaer, Ahmed Abdel-Latif, Stephen Frohwein, Timothy D. Henry, Richard A. Schatz, Nabil...> ;Circulation Research. 2017 Jan 20
• 94 citations
  The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina.
  Thomas J. Povsic, Timothy D. Henry, Jay H. Traverse, F. David Fortuin, Gary L. Schaer, Dean J. Kereiakes, Richard A. Schatz, Andreas M. Zeiher, Christopher J. White, D...> ;JACC. Cardiovascular Interventions. 2016 Aug 8
• 5 citations
  The History of Coronary Stenting.
  Christina Tan, Richard A. Schatz> ;Interventional Cardiology Clinics. 2016 Jul 1
• Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes From the ACT34-CMI Study.
  Henry TD, Schaer GL, Traverse JH, Povsic TJ, Davidson C, Lee JS, Costa MA, Bass T, Mendelsohn F, Fortuin FD, Pepine CJ, Patel AN, Riedel N, Junge C, Hunt A, Kereiakes ...> ;Cell Transplant. 2016-01-01
• 69 citations
  A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell a...
  Thomas J. Povsic, Candice Junge, Adel Nada, Richard A. Schatz, Robert A. Harrington, Charles J. Davidson, F. David Fortuin, Dean J. Kereiakes, Farrell O. Mendelsohn, W...> ;American Heart Journal. 2013 Jun 1
• 13 citations
  Incidence and clinical significance of cardiac biomarker elevation during stem cell mobilization, apheresis, and intramyocardial delivery: An analysis from ACT34-CMI
  Thomas J. Povsic, Douglas W. Losordo, Kenneth Story, Candice Junge, Richard A. Schatz, Robert A. Harrington, Timothy D. Henry> ;American Heart Journal. 2012 Nov 1
• 65 citations
  A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in pat...
  Thomas J. Povsic, Christopher M. O'Connor, Timothy D. Henry, Andrew Taussig, Dean J. Kereiakes, F. David Fortuin, Alan Niederman, Richard A. Schatz, Richard Spencer, D...> ;American Heart Journal. 2011 Oct 1
• Interventional cardiology in 2011- a look back.
  Richard A. Schatz, Rachel L Israel> ;The American Heart Hospital Journal. 2011 Jan 1
• 368 citations
  Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina
  Douglas W. Losordo, Timothy D. Henry, Charles J. Davidson, Joon S. Lee, Marco A. Costa, Theodore A. Bass, Farrell O. Mendelsohn, F. David Fortuin, Carl J. Pepine, Jay ...> ;Circulation Research. 2011 Aug 5
• 61 citations
  Recommendations for Successful Training on Methods of Delivery of Biologics for Cardiac Regeneration: A Report of the International Society for Cardiovascular Translat...
  Nabil Dib, Philippe Menasché, Jozef Bartunek, Andreas M. Zeiher, Andre Terzic, Nicolas A. Chronos, Timothy D. Henry, Nicholas S. Peters, Francisco Fernández-Avilés, Ma...> ;JACC. Cardiovascular Interventions. 2010 Mar 1
• 94 citations
  A Randomized Controlled Trial of Angiography Versus Intravascular Ultrasound-Directed Bare-Metal Coronary Stent Placement (The AVID Trial)
  Robert J. Russo, Patricia D. Silva, Paul S. Teirstein, Michael J. Attubato, Charles J. Davidson, Anthony C. DeFranco, Peter J. Fitzgerald, Steven L. Goldberg, James B....> ;Circulation. Cardiovascular Interventions. 2009 Apr 1
• 16 citations
  Relation of Periprocedural Bleeding Complications and Long-Term Outcome in Patients Undergoing Percutaneous Coronary Revascularization (from the Evaluation of Oral Xem...
  Jasper J. Brugts, Nestor Mercado, Stephen Hu, Mimi Guarneri, Matthew J. Price, Richard A. Schatz, Paul S. Teirstein, William Wijns, Patrick W. Serruys, William W. O'Ne...> ;The American Journal of Cardiology. 2009 Apr 1
• 9 citations
  Coronary artery aneurysm formation after drug-eluting stent implantation
  Justin P. Levisay, Ronald M. Roth, Richard A. Schatz> ;Cardiovascular Revascularization Medicine. 2008 Oct 1
• 524 citations
  Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation.
  Matthew J. Price, Sarah Endemann, Raghava R. Gollapudi, Rafael Valencia, Curtiss T. Stinis, Justin P. Levisay, Alissa Ernst, Neil Sawhney, Richard A. Schatz, Paul S. T...> ;European Heart Journal. 2008 Apr 1
• Join now to see all

Lectures

• SSO2 Therapy: Case Study 
  CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019